April 25th is DNA day. This day celebrates the completion of the Human Genome Project 20 years ago and the discovery of DNA’s double helix 70 years ago,…

As we come to the end of 2022 and our first year as a listed company, the year in review shows a clear theme of growth and expansion across…

New research shows how Optimer can speed projects by up to 75% compared to standard antibodies. Speeding project timelines can be vital to the development of any life science product. Whether…

Last week the government released their new Life Sciences Vision. This 10-year strategy for the sector aims to ensure that the United Kingdom builds a supportive environment for…

Aptamers function as chemical antibodies across a range of applications. From quality control reagents to point-of-care diagnostics and clinically relevant therapeutics, regardless of the end-use of the developed reagent,…

One thing we can all agree on is that 2020 has been a strange year. But for us at Aptamer Group, it’s also been…

At Aptamer Group, we’re determined to provide our customers and partners with the highest quality service. We’re excited to announce our new branding to reflect our commitment to…